Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Spectral X-Ray Diffraction using a 6 Megapixel Photon Counting Array Detector.

Muir RD, Pogranichniy NR, Muir JL, Sullivan SZ, Battaile KP, Mulichak AM, Toth SJ, Keefe LJ, Simpson GJ.

Proc SPIE Int Soc Opt Eng. 2015 Mar 12;9401:940109.

2.

Linear fitting of multi-threshold counting data with a pixel-array detector for spectral X-ray imaging.

Muir RD, Pogranichney NR, Muir JL, Sullivan SZ, Battaile KP, Mulichak AM, Toth SJ, Keefe LJ, Simpson GJ.

J Synchrotron Radiat. 2014 Sep;21(Pt 5):1180-7. doi: 10.1107/S1600577514014167. Epub 2014 Aug 15.

3.

Towards protein-crystal centering using second-harmonic generation (SHG) microscopy.

Kissick DJ, Dettmar CM, Becker M, Mulichak AM, Cherezov V, Ginell SL, Battaile KP, Keefe LJ, Fischetti RF, Simpson GJ.

Acta Crystallogr D Biol Crystallogr. 2013 May;69(Pt 5):843-51. doi: 10.1107/S0907444913002746. Epub 2013 Apr 19.

4.

Global radiation damage: temperature dependence, time dependence and how to outrun it.

Warkentin M, Hopkins JB, Badeau R, Mulichak AM, Keefe LJ, Thorne RE.

J Synchrotron Radiat. 2013 Jan;20(Pt 1):7-13. doi: 10.1107/S0909049512048303. Epub 2012 Nov 29.

5.

Global radiation damage at 300 and 260 K with dose rates approaching 1 MGy s⁻¹.

Warkentin M, Badeau R, Hopkins JB, Mulichak AM, Keefe LJ, Thorne RE.

Acta Crystallogr D Biol Crystallogr. 2012 Feb;68(Pt 2):124-33. doi: 10.1107/S0907444911052085. Epub 2012 Jan 17.

6.

Focusing, collimation and flux throughput at the IMCA-CAT bending-magnet beamline at the Advanced Photon Source.

Koshelev I, Huang R, Graber T, Meron M, Muir JL, Lavender W, Battaile K, Mulichak AM, Keefe LJ.

J Synchrotron Radiat. 2009 Sep;16(Pt 5):647-57. doi: 10.1107/S0909049509022353. Epub 2009 Jul 9.

PMID:
19713639
7.

Crystal structure of vancosaminyltransferase GtfD from the vancomycin biosynthetic pathway: interactions with acceptor and nucleotide ligands.

Mulichak AM, Lu W, Losey HC, Walsh CT, Garavito RM.

Biochemistry. 2004 May 11;43(18):5170-80.

PMID:
15122882
8.

Crystal structure of a tetrameric GDP-D-mannose 4,6-dehydratase from a bacterial GDP-D-rhamnose biosynthetic pathway.

Webb NA, Mulichak AM, Lam JS, Rocchetta HL, Garavito RM.

Protein Sci. 2004 Feb;13(2):529-39.

9.

Structure of the TDP-epi-vancosaminyltransferase GtfA from the chloroeremomycin biosynthetic pathway.

Mulichak AM, Losey HC, Lu W, Wawrzak Z, Walsh CT, Garavito RM.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9238-43. Epub 2003 Jul 21.

10.

The structure of mammalian cyclooxygenases.

Garavito RM, Mulichak AM.

Annu Rev Biophys Biomol Struct. 2003;32:183-206. Epub 2003 Feb 5. Review.

PMID:
12574066
11.

Structure of the MUR1 GDP-mannose 4,6-dehydratase from Arabidopsis thaliana: implications for ligand binding and specificity.

Mulichak AM, Bonin CP, Reiter WD, Garavito RM.

Biochemistry. 2002 Dec 31;41(52):15578-89.

PMID:
12501186
12.
13.

Mutational and X-ray crystallographic analysis of the interaction of dihomo-gamma -linolenic acid with prostaglandin endoperoxide H synthases.

Thuresson ED, Malkowski MG, Lakkides KM, Rieke CJ, Mulichak AM, Ginell SL, Garavito RM, Smith WL.

J Biol Chem. 2001 Mar 30;276(13):10358-65. Epub 2000 Dec 19.

14.

Prostaglandin endoperoxide H synthase-1: the functions of cyclooxygenase active site residues in the binding, positioning, and oxygenation of arachidonic acid.

Thuresson ED, Lakkides KM, Rieke CJ, Sun Y, Wingerd BA, Micielli R, Mulichak AM, Malkowski MG, Garavito RM, Smith WL.

J Biol Chem. 2001 Mar 30;276(13):10347-57. Epub 2000 Dec 19.

15.

Fatty-acid substrate interactions with cyclo-oxygenases.

Smith WL, Rieke CJ, Thuresson ED, Mulichak AM, Garavito RM.

Ernst Schering Res Found Workshop. 2000;(31):53-64. Review. No abstract available.

PMID:
10943327
16.

Peroxidase activity in prostaglandin endoperoxide H synthase-1 occurs with a neutral histidine proximal heme ligand.

Seibold SA, Cerda JF, Mulichak AM, Song I, Garavito RM, Arakawa T, Smith WL, Babcock GT.

Biochemistry. 2000 Jun 6;39(22):6616-24.

PMID:
10828979
17.

Crystal structure of SQD1, an enzyme involved in the biosynthesis of the plant sulfolipid headgroup donor UDP-sulfoquinovose.

Mulichak AM, Theisen MJ, Essigmann B, Benning C, Garavito RM.

Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13097-102.

18.
19.

Identification and SAR for a selective, nonpeptidyl thrombin inhibitor.

Naylor-Olsen AM, Ponticello GS, Lewis SD, Mulichak AM, Chen Z, Habecker CN, Phillips BT, Sanders WM, Tucker TJ, Shafer JA, Vacca JP.

Bioorg Med Chem Lett. 1998 Jul 7;8(13):1697-702.

PMID:
9873418
20.

The structure of mammalian hexokinase-1.

Mulichak AM, Wilson JE, Padmanabhan K, Garavito RM.

Nat Struct Biol. 1998 Jul;5(7):555-60.

PMID:
9665168
21.

Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position.

Feng DM, Gardell SJ, Lewis SD, Bock MG, Chen Z, Freidinger RM, Naylor-Olsen AM, Ramjit HG, Woltmann R, Baskin EP, Lynch JJ, Lucas R, Shafer JA, Dancheck KB, Chen IW, Mao SS, Krueger JA, Hare TR, Mulichak AM, Vacca JP.

J Med Chem. 1997 Nov 7;40(23):3726-33.

PMID:
9371237
22.

Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site.

Tucker TJ, Lumma WC, Mulichak AM, Chen Z, Naylor-Olsen AM, Lewis SD, Lucas R, Freidinger RM, Kuo LC.

J Med Chem. 1997 Mar 14;40(6):830-2. No abstract available.

PMID:
9083470
23.

Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution.

Chen Z, Li Y, Mulichak AM, Lewis SD, Shafer JA.

Arch Biochem Biophys. 1995 Sep 10;322(1):198-203.

PMID:
7574675
24.

Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors.

Romines KR, Watenpaugh KD, Tomich PK, Howe WJ, Morris JK, Lovasz KD, Mulichak AM, Finzel BC, Lynn JC, Horng MM, et al.

J Med Chem. 1995 May 26;38(11):1884-91.

PMID:
7783120
25.

The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors.

Mulichak AM, Hui JO, Tomasselli AG, Heinrikson RL, Curry KA, Tomich CS, Thaisrivongs S, Sawyer TK, Watenpaugh KD.

J Biol Chem. 1993 Jun 25;268(18):13103-9.

26.

The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4.

Wu TP, Padmanabhan K, Tulinsky A, Mulichak AM.

Biochemistry. 1991 Oct 29;30(43):10589-94.

PMID:
1657149
27.

Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution.

Mulichak AM, Tulinsky A, Ravichandran KG.

Biochemistry. 1991 Oct 29;30(43):10576-88.

PMID:
1657148
28.

Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4.

Mulichak AM, Tulinsky A.

Blood Coagul Fibrinolysis. 1990 Dec;1(6):673-9.

PMID:
1966798
29.

Human plasminogen kringle 4. Crystallization and preliminary diffraction data of two different crystal forms.

Mulichak AM, Park CH, Tulinsky A, Petros AM, Llinás M.

J Biol Chem. 1989 Feb 5;264(4):1922-3.

30.

Crystallization and preliminary diffraction data of Escherichia coli ADP glucose pyrophosphorylase.

Mulichak AM, Skrzypczak-Jankun E, Rydel TJ, Tulinsky A, Preiss J.

J Biol Chem. 1988 Nov 25;263(33):17237-8.

Supplemental Content

Loading ...
Support Center